» Articles » PMID: 31028676

Fluorescence-Based Functional Assays for Ca-Permeable ThermoTRP Channels

Overview
Specialty Molecular Biology
Date 2019 Apr 28
PMID 31028676
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Transient receptor potential (TRP) ion channels are involved in a variety of fundamental physiological processes, and their malfunction produces numerous human diseases. Therefore, these proteins represent a class of attractive drug targets and a class of important off-targets for in vitro pharmacological profiling. In the past decades, the rapid progress in emerging functional assays and instrumentation has enabled to readily monitor thermoTRP channel activity, and to develop high throughput screening (HTS) assays for TPR drug discovery. Chronologically, functional methods for ion channels include the ligand binding assay, flux-based assay, electrophysiology, fluorescence-based assays, and, more recently, automated electrophysiological assays. Here we described the methodology used to monitor the functionality of two thermoTRPs, TRPV1 and TRPM8, based on Ca microfluorography using a 96-well fluorescence plate reader that allows the implementation of a medium- to high-throughput format ideal for drug screening.

Citing Articles

Genetically-encoded BRET probes shed light on ligand bias-induced variable ion selectivity in TRPV1 and P2X5/7.

Chappe Y, Pierredon S, Joushomme A, Molle P, Garenne A, Canovi A Proc Natl Acad Sci U S A. 2022; 119(46):e2205207119.

PMID: 36343259 PMC: 9674215. DOI: 10.1073/pnas.2205207119.


A Review on the Role of TRP Channels and Their Potential as Drug Targets_An Insight Into the TRP Channel Drug Discovery Methodologies.

Fallah H, Ahuja E, Lin H, Qi J, He Q, Gao S Front Pharmacol. 2022; 13:914499.

PMID: 35685622 PMC: 9170958. DOI: 10.3389/fphar.2022.914499.


In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening.

Iraci N, Ostacolo C, Medina-Peris A, Ciaglia T, Novoselov A, Altieri A Int J Mol Sci. 2022; 23(4).

PMID: 35216186 PMC: 8877448. DOI: 10.3390/ijms23042070.